TITLE:
Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0653A , ezetimibe (+) simvastatin

SUMMARY:

      A 6-week treatment study to compare the reduction in cholesterol of two drugs
      MK0653A+Simvastatin for high cholesterol, in patients with hypercholesterolemia and
      atherosclerotic or coronary vascular disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        - Men and women greater than or equal to 18 years of age with elevated cholesterol levels
        and coronary heart disease (CHD), or atherosclerotic vascular disease may be eligible to
        participate in this study.
      
